Logo image of PCE1.DE

BOOKING HOLDINGS INC (PCE1.DE) Stock Fundamental Analysis

FRA:PCE1 - Deutsche Boerse Ag - US09857L1089 - Common Stock - Currency: EUR

4267  -214 (-4.78%)

Fundamental Rating

6

Taking everything into account, PCE1 scores 6 out of 10 in our fundamental rating. PCE1 was compared to 55 industry peers in the Hotels, Restaurants & Leisure industry. PCE1 gets an excellent profitability rating and is at the same time showing great financial health properties. PCE1 shows excellent growth, but is valued quite expensive already. This makes PCE1 very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

PCE1 had positive earnings in the past year.
In the past year PCE1 had a positive cash flow from operations.
PCE1 had positive earnings in each of the past 5 years.
Each year in the past 5 years PCE1 had a positive operating cash flow.
PCE1.DE Yearly Net Income VS EBIT VS OCF VS FCFPCE1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

1.2 Ratios

The Return On Assets of PCE1 (21.23%) is better than 98.18% of its industry peers.
With an excellent Return On Invested Capital value of 50.00%, PCE1 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PCE1 is significantly above the industry average of 11.55%.
The 3 year average ROIC (39.14%) for PCE1 is below the current ROIC(50.00%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 21.23%
ROE N/A
ROIC 50%
ROA(3y)16.97%
ROA(5y)11.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.14%
ROIC(5y)26.17%
PCE1.DE Yearly ROA, ROE, ROICPCE1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

PCE1's Profit Margin of 24.78% is amongst the best of the industry. PCE1 outperforms 94.55% of its industry peers.
In the last couple of years the Profit Margin of PCE1 has declined.
PCE1's Operating Margin of 31.97% is amongst the best of the industry. PCE1 outperforms 94.55% of its industry peers.
In the last couple of years the Operating Margin of PCE1 has remained more or less at the same level.
Industry RankSector Rank
OM 31.97%
PM (TTM) 24.78%
GM N/A
OM growth 3Y13.4%
OM growth 5Y-1.21%
PM growth 3Y32.58%
PM growth 5Y-5.16%
GM growth 3YN/A
GM growth 5YN/A
PCE1.DE Yearly Profit, Operating, Gross MarginsPCE1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

7

2. Health

2.1 Basic Checks

PCE1 has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
PCE1 has less shares outstanding than it did 1 year ago.
PCE1 has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, PCE1 has a worse debt to assets ratio.
PCE1.DE Yearly Shares OutstandingPCE1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
PCE1.DE Yearly Total Debt VS Total AssetsPCE1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

An Altman-Z score of 6.69 indicates that PCE1 is not in any danger for bankruptcy at the moment.
PCE1 has a better Altman-Z score (6.69) than 100.00% of its industry peers.
PCE1 has a debt to FCF ratio of 2.10. This is a good value and a sign of high solvency as PCE1 would need 2.10 years to pay back of all of its debts.
PCE1 has a better Debt to FCF ratio (2.10) than 83.64% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.1
Altman-Z 6.69
ROIC/WACC5.62
WACC8.89%
PCE1.DE Yearly LT Debt VS Equity VS FCFPCE1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

PCE1 has a Current Ratio of 1.31. This is a normal value and indicates that PCE1 is financially healthy and should not expect problems in meeting its short term obligations.
PCE1's Current ratio of 1.31 is fine compared to the rest of the industry. PCE1 outperforms 78.18% of its industry peers.
PCE1 has a Quick Ratio of 1.31. This is a normal value and indicates that PCE1 is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of PCE1 (1.31) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
PCE1.DE Yearly Current Assets VS Current LiabilitesPCE1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.27% over the past year.
Measured over the past years, PCE1 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.66% on average per year.
The Revenue has grown by 11.11% in the past year. This is quite good.
PCE1 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.52% yearly.
EPS 1Y (TTM)22.27%
EPS 3Y60.13%
EPS 5Y12.66%
EPS Q2Q%29.84%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y29.39%
Revenue growth 5Y9.52%
Sales Q2Q%14.36%

3.2 Future

PCE1 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.76% yearly.
The Revenue is expected to grow by 8.26% on average over the next years. This is quite good.
EPS Next Y12.89%
EPS Next 2Y14.16%
EPS Next 3Y14.86%
EPS Next 5Y18.76%
Revenue Next Year7.89%
Revenue Next 2Y8.25%
Revenue Next 3Y8.66%
Revenue Next 5Y8.26%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
PCE1.DE Yearly Revenue VS EstimatesPCE1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
PCE1.DE Yearly EPS VS EstimatesPCE1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100 200 300 400 500

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.68, the valuation of PCE1 can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as PCE1.
PCE1 is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 21.86, which indicates a rather expensive current valuation of PCE1.
PCE1's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.10. PCE1 is around the same levels.
Industry RankSector Rank
PE 24.68
Fwd PE 21.86
PCE1.DE Price Earnings VS Forward Price EarningsPCE1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as PCE1.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PCE1 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 19.26
EV/EBITDA 18.64
PCE1.DE Per share dataPCE1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 -200 400 600

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PCE1 does not grow enough to justify the current Price/Earnings ratio.
PCE1 has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as PCE1's earnings are expected to grow with 14.86% in the coming years.
PEG (NY)1.92
PEG (5Y)1.95
EPS Next 2Y14.16%
EPS Next 3Y14.86%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.76%, PCE1 is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.93, PCE1 has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, PCE1's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PCE1.DE Yearly Dividends per sharePCE1.DE Yearly Dividends per shareYearly Dividends per share 2024 2025 10 20 30

5.3 Sustainability

PCE1 pays out 19.96% of its income as dividend. This is a sustainable payout ratio.
DP19.96%
EPS Next 2Y14.16%
EPS Next 3Y14.86%
PCE1.DE Yearly Income VS Free CF VS DividendPCE1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
PCE1.DE Dividend Payout.PCE1.DE Dividend Payout, showing the Payout Ratio.PCE1.DE Dividend Payout.PayoutRetained Earnings

BOOKING HOLDINGS INC

FRA:PCE1 (3/7/2025, 7:00:00 PM)

4267

-214 (-4.78%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners94.14%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap140.04B
Analysts77.78
Price Target5428.16 (27.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend32.11
Dividend Growth(5Y)N/A
DP19.96%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.58%
Min EPS beat(2)6.1%
Max EPS beat(2)13.06%
EPS beat(4)4
Avg EPS beat(4)17.03%
Min EPS beat(4)6.1%
Max EPS beat(4)41.9%
EPS beat(8)8
Avg EPS beat(8)14.1%
EPS beat(12)12
Avg EPS beat(12)38.27%
EPS beat(16)15
Avg EPS beat(16)29.7%
Revenue beat(2)2
Avg Revenue beat(2)3.13%
Min Revenue beat(2)2.74%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)1.9%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)3.52%
Revenue beat(8)4
Avg Revenue beat(8)1.03%
Revenue beat(12)7
Avg Revenue beat(12)0.97%
Revenue beat(16)10
Avg Revenue beat(16)1.77%
PT rev (1m)2.71%
PT rev (3m)11.29%
EPS NQ rev (1m)-17.94%
EPS NQ rev (3m)-19.96%
EPS NY rev (1m)-0.36%
EPS NY rev (3m)-1.04%
Revenue NQ rev (1m)-1.9%
Revenue NQ rev (3m)-3.24%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)-0.74%
Valuation
Industry RankSector Rank
PE 24.68
Fwd PE 21.86
P/S 6.4
P/FCF 19.26
P/OCF 18.27
P/B N/A
P/tB N/A
EV/EBITDA 18.64
EPS(TTM)172.91
EY4.05%
EPS(NY)195.19
Fwd EY4.57%
FCF(TTM)221.54
FCFY5.19%
OCF(TTM)233.58
OCFY5.47%
SpS666.21
BVpS-112.82
TBVpS-230.15
PEG (NY)1.92
PEG (5Y)1.95
Profitability
Industry RankSector Rank
ROA 21.23%
ROE N/A
ROCE 62.92%
ROIC 50%
ROICexc N/A
ROICexgc N/A
OM 31.97%
PM (TTM) 24.78%
GM N/A
FCFM 33.25%
ROA(3y)16.97%
ROA(5y)11.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.14%
ROIC(5y)26.17%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)49.26%
ROCE(5y)32.93%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y13.4%
OM growth 5Y-1.21%
PM growth 3Y32.58%
PM growth 5Y-5.16%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.1
Debt/EBITDA 1.82
Cap/Depr 72.59%
Cap/Sales 1.81%
Interest Coverage 7.96
Cash Conversion 101.75%
Profit Quality 134.21%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 6.69
F-Score7
WACC8.89%
ROIC/WACC5.62
Cap/Depr(3y)74.21%
Cap/Depr(5y)71.46%
Cap/Sales(3y)1.86%
Cap/Sales(5y)2.51%
Profit Quality(3y)166.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.27%
EPS 3Y60.13%
EPS 5Y12.66%
EPS Q2Q%29.84%
EPS Next Y12.89%
EPS Next 2Y14.16%
EPS Next 3Y14.86%
EPS Next 5Y18.76%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y29.39%
Revenue growth 5Y9.52%
Sales Q2Q%14.36%
Revenue Next Year7.89%
Revenue Next 2Y8.25%
Revenue Next 3Y8.66%
Revenue Next 5Y8.26%
EBIT growth 1Y29.95%
EBIT growth 3Y46.73%
EBIT growth 5Y8.2%
EBIT Next Year20.7%
EBIT Next 3Y14.34%
EBIT Next 5Y13.97%
FCF growth 1Y12.79%
FCF growth 3Y46.4%
FCF growth 5Y11.91%
OCF growth 1Y13.33%
OCF growth 3Y43.44%
OCF growth 5Y11.34%